Regenxbio (RGNX) Misses Q1 EPS by 15c

Regenxbio (NASDAQ: RGNX) reported Q1 EPS of ($1.53), $0.15 worse than the analyst estimate of ($1.38). Revenue for the quarter came in at $19.14 million versus the consensus estimate of $31.97 million.

For earnings history and earnings-related data on Regenxbio (RGNX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Regenxbio Inc. (RGNX) PT Lowered to $23 at H.C. Wainwright